Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Among reforms, institute urges a new method of paying for CME in US

This article was originally published in Scrip

Executive Summary

The US Institute of Medicine's Conflict of Interest in Medical Research, Education and Practice committee has issued a far-reaching report outlining how it believes physicians should reject many financial arrangements with pharmaceutical firms. One troublesome area remains industry funding of continuing medical education (CME) courses, which are required of many US physicians. The committee has not called for total elimination of industry support for CME, but rather urges a "new system of funding CME ... free of industry influence".

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC001864

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel